Venmax Drugs & Pharmaceuticals standalone net profit rises 300.00% in the June 2025 quarter
Net profit of Venmax Drugs & Pharmaceuticals rose 300.00% to Rs 0.04 crore in the quarter ended June 2025 as against Rs 0.01 crore during the previous quarter ended June 2024. Sales rose 1110.00% to Rs 1.21 crore in the quarter ended June 2025 as against Rs 0.10 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 1.21 | 0.10 | 1110 |
| OPM % | 3.31 | -20.00 | - |
| PBDT | 0.04 | 0.01 | 300 |
| PBT | 0.04 | 0.01 | 300 |
| NP | 0.04 | 0.01 | 300 |